Using mRNA to stop HIV from hiding away in white blood cells could be the key to developing a way to eradicate the infection, rather than simply managing viral levels in the body. The tantalising ...

Some notable examples of personalized mRNA products include Gritstone bio’s GRANITE and Moderna’s vaccine mRNA-4157, which are expected to enter the market in Q2 2027 and Q3 2030, respectively.

BioNTech has agreed to buy another specialist in mRNA-based vaccines and therapeutics, fellow German biotech CureVac, in an all-stock deal valued at around $1.25 billion. Under the terms of the ...

Cajal bodies are regions within the nucleus that are enriched in proteins and RNAs involved in mRNA processing. They are the main sites for the assembly of small nuclear ribonucleoproteins (snRNPs ...

Beyond mRNA-based diagnostic tests, mRNA has also shown early promise as a therapy for cancer patients, enabling personalized treatment that could more effectively target one’s tumor.

Two other components making moves today are Lockheed Martin, trading down 1.6%, and Incyte, trading up 4.3% on the day. VIDEO: S&P 500 Movers: MRNA, PLTR The views and opinions expressed herein ...

BioNTech, a biotech company best known for its successful development of a messenger RNA Covid-19 vaccine, is acquiring fellow mRNA company CureVac in a $1.25 billion stock deal that brings ...

The Trump administration's cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health security ...

Stay Informed on MRNA's Latest Pre Market Trades. Get the most current trading insights on Moderna, Inc. Common Stock (MRNA) with Nasdaq.

Myocarditis, or inflammation of the heart muscle, is of particular concern among mRNA vaccine opponents. An analysis published in 2022 found that myocarditis occurred in about 31.2 cases per 1 ...